Dermata Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.23
|
0.00
|
0.23
|
100.00%
|
|
2022-09-30
|
-0.22
|
-0.20
|
0.02
|
9.09%
|
|
2022-06-30
|
-0.32
|
-0.24
|
0.08
|
25.00%
|
|
2022-03-31
|
-0.40
|
-0.33
|
0.07
|
17.50%
|
|
2021-12-31
|
-0.35
|
-0.26
|
0.09
|
25.71%
|
|
2021-09-30
|
-0.46
|
-0.86
|
-0.40
|
-86.96%
|
|
2021-06-30
|
-1.41
|
-0.70
|
0.71
|
50.35%
|
|
2020-12-31
|
0.00
|
-1.21
|
-1.21
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.77
|
|
2021-12-31
|
-1.82
|
|
2020-12-31
|
-1.21
|
|
2019-12-31
|
-0.74
|